PLACEBO, 1-ISOPROPYLNORADRENOCHROME-5-MONOSEMICARBAZONO AND PIZOTIFEN IN MIGRAINE PROPHYLAXISKANGASNIEMI P.1979; HEADACHE; USA; DA. 1979; VOL. 19; NO 4; PP. 219-222; BIBL. 10 REF.Article

VARIATION OF PLASMA FREE TRYPTOPHAN AND CSF 5-HIAA DURING MIGRAINE.HYYPPA MT; KANGASNIEMI P.1977; HEADACHE; U.S.A.; DA. 1977; VOL. 17; NO 1; PP. 25-27; BIBL. 21 REF.Article

MIGRAINE HEADACHE AND BLOOD SEROTONIN LEVELS AFTER ADMINISTRATION OF ZIMELIDINE, A SELECTIVE INHIBITOR OF SEROTONIN UPTAKESYVALAHTI E; KANGASNIEMI P; ROSS SB et al.1979; CURR. THERAPEUT. RES.; USA; DA. 1979; VOL. 25; NO 2; PP. 299-310; BIBL. 15 REF.Article

Ketoprofen and ergotamine in acute migraineKANGASNIEMI, P; KAAJA, R.Journal of internal medicine. 1992, Vol 231, Num 5, pp 551-554, issn 0954-6820Article

VALUE OF HIGH CONTRAST MEDIUM DOSE IN BRAIN CTRAININKO R; MAJURIN ML; VIRTAMA P et al.1982; J. COMPUT. ASSISTED TOMOGR.; ISSN 0363-8715; USA; DA. 1982; VOL. 6; NO 1; PP. 54-57; BIBL. 12 REF.Article

VISUAL EVOKED POTENTIALS IN MENSTRUAL MIGRAINELEHTONEN J; HYYPPA MT; KAIHOLA HL et al.1979; HEADACHE; USA; DA. 1979; VOL. 19; NO 2; PP. 63-70; BIBL. 31 REF.Article

Transient asymmetries of steady-state visual evoked potentials in classic migraineNYRKE, T; KANGASNIEMI, P; LANG, A. H et al.Headache. 1990, Vol 30, Num 3, pp 133-137, issn 0017-8748Article

Difference of steady-state visual evoked potentials in classic and common migraineNYRKE, T; KANGASNIEMI, P; LANG, A. H et al.Electroencephalography and clinical neurophysiology. 1989, Vol 73, Num 4, pp 285-294, issn 0013-4694Article

Steady-state visual evoked potentials during migraine prophylaxis by propranolol and femoxetineNYRKE, T; KANGASNIEMI, P; LANG, A. H et al.Acta neurologica scandinavica. 1984, Vol 69, Num 1, pp 9-14, issn 0001-6314Article

Femoxetine ― a new 5-HT uptake inhibitor- and propranolol in the prophylactic treatment of migraineKANGASNIEMI, P. J; MYRKE, T; LANG, A. H et al.Acta neurologica scandinavica. 1983, Vol 68, Num 4, pp 262-267, issn 0001-6314Article

The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraineFACCHINETTI, F; BONELLIE, G; KANGASNIEMI, P et al.Obstetrics and gynecology (New York. 1953). 1995, Vol 86, Num 6, pp 911-916, issn 0029-7844Article

Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine : Comparable effect in a double-blind, randomized, controlled, parallel-group studyMYLLYLÄ, V. V; HAVANKA, H; HERRALA, L et al.Headache. 1998, Vol 38, Num 3, pp 201-207, issn 0017-8748Article